Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson (

Once Valued At $21B, Avon Files For Bankruptcy Following Lawsuits For 'Cancer-causing' Products

Avon Products Inc. is declaring bankruptcy in the face of numerous lawsuits claiming that the talcum powder in its products causes cancer.

International Business Times UK

3 Bargain Healthcare Stocks to Buy for Long-Term Gains

The healthcare sector is poised for significant growth, driven by advancements in drug development, ongoing research and development (R&D) efforts, and its ability to remain resilient even during economic downturns. Thus, investors might consider buying bargain pharma stocks: Johnson & Johnson (JNJ), Merck & Co. (MRK), and AbbVie (ABBV) for…

StockNews.com

Is It Time to Buy These Overlooked Dividend Stocks?

These defensive healthcare picks from the Dow Jones Industrial Average are worth a look at current levels for investors seeking passive income.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Top Stocks for Dividend Reinvestment Plans (DRIPs)

DRIPs offer a compelling strategy to boost investment returns. This approach helps to compound your gains over time by reinvesting dividends to buy more stock and reducing risk through dollar-cost investing. Top stocks, including Johnson & Johnson (JNJ), Coca-Cola (KO), and PepsiCo (PEP), are ideal for reinvesting dividends to maximize…

StockNews.com

Is Wall Street Bullish or Bearish on Johnson & Johnson Stock?

Despite Johnson & Johnson’s relative underperformance over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

3 Healthcare Stocks Benefiting From an Aging Population

The healthcare industry is set for growth due to the growing demand for quality healthcare services and the aging population. Hence, quality healthcare stocks, such as Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck & Co. (MRK), might be worth looking into. Read more….

StockNews.com

3 Pharmaceutical Stocks With Strong Pipelines

The pharmaceutical industry is flourishing due to increasing medical demands and rising healthcare spending worldwide. Hence, pharma stocks Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck & Co. (MRK), with strong pipelines, might be worth buying. Read more….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Stock Market Today: Semis Get Slammed and Blue Chips Bounce

The potential for more curbs on tech sales to China set off a rotation into blue chips.

Kiplinger

Broader Market Slides as Chip Stocks Plunge

The S&P 500 Index ($SPX ) (SPY ) today is down -1.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.29%. Stock indexes today are mixed, with the Dow Jones Industrials posting a new record...

Barchart

Johnson & Johnson Earnings Preview: What to Expect

Johnson & Johnson is expected to release its second-quarter earnings next week, and analysts project a low single-digit profit dip.

Barchart

WHO Agency Says Talc Is 'Probably' Cancer-causing

The World Health Organization's cancer agency on Friday classified talc as "probably carcinogenic" for humans, however an outside expert warned against misinterpreting the announcement as a "smoking gun".

International Business Times

3 Highest-yield Dividend Kings To Buy This Summer

Looking for income this summer? Here are three quality companies that'll put a few extra dollars in your pocket.

Barchart

How 4 Ordinary People Invested To Reach Financial Goals

Patience helped these four investors make their portfolios work for them.

Kiplinger

3 Blue-Chip Stocks Offering Stability

Blue-chip companies, characterized by large capitalization, global footprint, solid financial performance, robust balance sheet, and dominant market position, are favored by investors seeking stability and long-term growth potential. Thus, quality blue-chip stocks Microsoft (MSFT), Procter & Gamble (PG), and Johnson & Johnson (JNJ) could be attractive buys for steady returns.…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

Al Jazeera

Johnson & Johnson to pay $700m to settle claims it misled consumers

Pharmaceutical giant’s payout settles allegations it misled consumers about safety of its talcum-based powder products.

StockNews.com

Top 4 Pharma Stocks for Long-Term Value Investors in 2024

The pharmaceutical sector is experiencing rapid growth thanks to the rising demand for precision drugs, the growing geriatric population, and an uptick in chronic diseases. Given this backdrop, long-term value investors could consider buying and holding quality pharmaceutical stocks such as Organon (OGN), Procaps (PROC), Johnson & Johnson (JNJ), and…

Top News

Cancer Victims Sue Johnson & Johnson Over Bankruptcy Allegations

Johnson & Johnson faces legal action over alleged fraudulent bankruptcies related to talc products causing cancer.

Barchart

5 Standout Healthcare Dividend Stocks to Consider Now

Amid healthcare’s enduring importance and increasing demand for its products and services, here are five dividend-paying healthcare stocks to consider now.

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times

J&J Unveils Landmark $6.5 Billion Settlement With Baby Powder Ovarian Cancer Claimants

J&J has reached a new $6.5 billion settlement with those who claimed that the company's baby powder causes ovarian cancer.

The Guardian - UK

Medical device companies pay millions to NHS while pushing products, says study

Pharmaceutical equipment firms are funding NHS staff and training while promoting sales

Top News

WHO To Issue Alert On Contaminated J&J Cough Syrup

WHO may issue a broader alert for contaminated Johnson & Johnson cough syrup in Africa, highlighting public health risks and the importance of regulatory v...

Top News

J&J Prevails In Talc Lawsuit Over Cancer Allegations

Johnson & Johnson wins trial over cancer claims related to baby powder in Florida. Company maintains product safety amidst ongoing legal battles.

Top News

Top Companies Leading In Corporate Governance Practices

Discover the top 10 companies with exceptional corporate governance practices, including Apple, Microsoft, and Johnson & Johnson.

Barchart

Stocks Mixed on Rising Bond Yields

The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.05%. Stock indexes this morning are mixed, with the Nasdaq 100 falling to a...

StockNews.com

JNJ Earnings Forecast - Is Pharmaceutical Industry Set for Shake-up?

As pharma titan Johnson & Johnson (JNJ) gears up to unveil its first-quarter results on April 16, 2024, anticipation looms over the pharmaceutical industry. JNJ’s recent acquisitions signal the company’s strategic expansions, and given its history as one of the prominent pharma companies, is JNJ’s forecast as stunning? Let us…

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

914 stories

Alphabet Inc

616 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.